Drug-Free Pain Relief Technology with Premium Wraps FREDERICK, Md., Nov. 6, 2020 /PRNewswire/ — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.comis pleased to announce the execution of a commercial partnership agreement with Scott Specialties Inc (SS http://scottspecialties.com/) to bring their innovative pain management devices to the retail consumer healthcare marketplace under the DonJoy® (DJO www.djoglobal.com) Advantage product line. This commercial … Continue Reading
Category
News
Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation
FREDERICK, MD, June 15, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today that it has appointed Richard Staelin, Ph.D. as the Chairman of the Board following the resignation and retirement of Ms. Patricia Whelan. “The management team at BioElectronics thanks Patricia Whelan for her … Continue Reading
BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain
FREDERICK, MD- February 3, 2020 – BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to announce that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new, over-the counter marketing clearance was granted for the drug free ActiPatch® medical device, for the … Continue Reading
BioElectronics Announces New Management Team
FREDERICK, MD- November 15, 2019 – BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that after seeking legal counsel a Board of Directors, President and Chief Executive Officer have been appointed/re-affirmed. These changes follow the unexpected passing of the Company’s founder, President and CEO Mr. Andrew Whelan, in October 2019. Pursuant to Section … Continue Reading
BioElectronics Founder and CEO Andrew J. Whelan Has Died Suddenly
FREDERICK, MD, Oct. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corp. (OTCPK: BIEL) is sad to announce that its founder and CEO, Andrew J. Whelan, died suddenly last night at his home in Frederick, Maryland. The BioElectronics management team will continue to manage day-to-day operations until a permanent replacement can be confirmed. Mr. … Continue Reading
BioElectronics Announces Publication of a Study of the ActiPatch® Medical Device as an Effective Long Term Treatment for Chronic Pain
FREDERICK, MD- Oct 02, 2019 – BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com , the maker of non-invasive electroceutical devices, is pleased to announce the publication of a study in the journal Pain Research and Management, titled “A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy”. The study demonstrated that users who … Continue Reading
BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug
FREDERICK, MD, Aug. 20, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has filed a 510(k), Premarket Notification application with the U.S. Food and Drug Administration (FDA). The application is to seek expanded market clearance for the drug free, over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical … Continue Reading
The Stock Day Podcast Hosts BioElectronics’ to Discuss Its New Technology To Mitigate Opioid Use
PHOENIX, AZ / ACCESSWIRE / July 10, 2019 / The Stock Day Podcast welcomed BioElectronics Corporation (BIEL) (“the Company”), a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices. Vice President of Sales, Keith Nalepka, joined Stock Day host Everett Jolly. Jolly began the interview by asking … Continue Reading
BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy
FREDERICK, MD, July 01, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to announce that it has received market clearance from the United States Food and Drug Administration (US FDA) for its RecoveryRx® medical device, for the treatment of postoperative pain. Physicians are … Continue Reading
BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Pain
FREDERICK, MD, June 03, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to announce the publication of a registry study in the May 2019 edition of the Journal of Pain Management. Titled “Chronic pain intervention using pulsed shortwave therapy: the relationship between … Continue Reading